within Pharmacolibrary.Drugs.ATC.B;

model B06AB01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.6333333333333333,
    adminDuration  = 600,
    adminMass      = 0.4,
    adminCount     = 1,
    Vd             = 0.0034,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Hemin is an iron-containing metalloporphyrin used primarily for the treatment of acute intermittent porphyria and related acute porphyrias. It is administered as a heme replacement to suppress the hepatic production of porphyrin precursors. Hemin is currently approved for medical use by major regulatory agencies such as FDA.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for adult patients with acute intermittent porphyria, following intravenous administration. Published clinical PK data for hemin are limited; the following values are estimated based on sparse literature and product information.</p><h4>References</h4><ol><li><p>Syed, YY (2021). Givosiran: A Review in Acute Hepatic Porphyria. <i>Drugs</i> 81(7) 841–848. DOI:<a href=&quot;https://doi.org/10.1007/s40265-021-01511-3&quot;>10.1007/s40265-021-01511-3</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33871817/&quot;>https://pubmed.ncbi.nlm.nih.gov/33871817</a></p></li><li><p>Siegert, SW, &amp; Holt, RJ (2008). Physicochemical properties, pharmacokinetics, and pharmacodynamics of intravenous hematin: a literature review. <i>Advances in therapy</i> 25(9) 842–857. DOI:<a href=&quot;https://doi.org/10.1007/s12325-008-0094-y&quot;>10.1007/s12325-008-0094-y</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/18777015/&quot;>https://pubmed.ncbi.nlm.nih.gov/18777015</a></p></li><li><p>Habtezion, A, et al., &amp; Omary, MB (2011). Panhematin provides a therapeutic benefit in experimental pancreatitis. <i>Gut</i> 60(5) 671–679. DOI:<a href=&quot;https://doi.org/10.1136/gut.2010.217208&quot;>10.1136/gut.2010.217208</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/21159893/&quot;>https://pubmed.ncbi.nlm.nih.gov/21159893</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end B06AB01;
